Aya Ohtsubo

发表

Frequent Germline and Somatic Single Nucleotide Variants in the Promoter Region of the Ribosomal RNA Gene in Japanese Lung Adenocarcinoma Patients

Shujiro Okuda, P. Schraml, A. Miyashita, 2020, Cells.

The Prognostic Significance of the Continuous Administration of Anti-PD-1 Antibody via Continuation or Rechallenge After the Occurrence of Immune-Related Adverse Events

Kazuhiro Sato, Hiroshi Tanaka, Aya Ohtsubo, 2021, Frontiers in Oncology.

Prognostic significance of procalcitonin in small cell lung cancer

Aya Ohtsubo, Kosuke Ichikawa, T. Kikuchi, 2021, Translational lung cancer research.

PD-1 blockade therapy augments the antitumor effects of lymphodepletion and adoptive T cell transfer

Miyuki Sato, Aya Ohtsubo, Kosuke Ichikawa, 2021, Cancer Immunology, Immunotherapy.

Transfer of in vitro-expanded naïve T cells after lymphodepletion enhances antitumor immunity through the induction of polyclonal antitumor effector T cells

Miyuki Sato, Aya Ohtsubo, Kosuke Ichikawa, 2017, PloS one.

Subsequent systemic therapy for non-small cell lung cancer patients with immune checkpoint inhibitor-related interstitial lung disease

Kazuhiro Sato, Hiroshi Tanaka, Aya Ohtsubo, 2021, Translational lung cancer research.

Phase II Trial of the Combination of Alectinib with Bevacizumab in Alectinib Refractory ALK-Positive Nonsquamous Non-Small-Cell Lung Cancer (NLCTG1501)

K. Nishio, Daisuke Ishikawa, T. Sekiya, 2022, Cancers.

Combination therapy of cisplatin with cilastatin enables an increased dose of cisplatin, enhancing its antitumor effect by suppression of nephrotoxicity

Miyuki Sato, Aya Ohtsubo, Kosuke Ichikawa, 2021, Scientific Reports.

DDX3X mediates EGFR-TKI resistance through VEGFR signaling

Takaaki Masuda, T. Sekiya, Aya Ohtsubo, 2021 .

DDX3X Induces Primary EGFR-TKI Resistance Based on Intratumor Heterogeneity in Lung Cancer Cells Harboring EGFR-Activating Mutations

I. Narita, Aya Ohtsubo, H. Kagamu, 2014, PloS one.

Nephrotoxicity of cisplatin combination chemotherapy in thoracic malignancy patients with CKD risk factors

I. Narita, Daisuke Ishikawa, Aya Ohtsubo, 2016, BMC Cancer.

[A Case of Pneumatosis Cystoides Intestinalis Secondary to Gefitinib Therapy for Lung Adenocarcinoma].

T. Wakai, K. Takizawa, Aya Ohtsubo, 2015, Gan to kagaku ryoho. Cancer & chemotherapy.

Efficacy and safety of amrubicin therapy after chemoimmunotherapy in small cell lung cancer patients

Aya Ohtsubo, Kosuke Ichikawa, T. Kikuchi, 2021, Translational lung cancer research.

Nephrotoxicity of cisplatin combination chemotherapy in thoracic malignancy patients with CKD risk factors

I. Narita, Daisuke Ishikawa, Aya Ohtsubo, 2016, BMC Cancer.

18F-FDG-PET/CT Uptake by Noncancerous Lung as a Predictor of Interstitial Lung Disease Induced by Immune Checkpoint Inhibitors

Aya Ohtsubo, K. Nozaki, Rie Kondo, 2024, Academic Radiology.